A Randomized Controlled Trial of Precision Therapy in Early-Stage Hypertension
Sarah J. Thompson, Michael R. Patel, Emily K. Lawson, Daniel Ortiz, et al.
DOI: 10.1234/vmj.2025.56789
Hypertension remains a leading risk factor for cardiovascular disease worldwide. This randomized controlled trial evaluates the efficacy and safety of precision therapy compared to standard care in patients with early-stage hypertension…
